Ambev SA (ADR) (ABEV) Reaches $6.49 52-Week High; Morgan Stanley Asia-pacific Fund (APF)’s Sentiment Is 0.87

September 11, 2017 - By Kurt Siggers

The Morgan Stanley Asia-Pacific Fund, Inc. is a diversified, closed-end management investment company. The company has market cap of $232.34 million. The Fund’s investment objective is long-term capital appreciation through investments primarily in equity securities of Asian-Pacific issuers and in debt securities issued or guaranteed by Asian Pacific governments or governmental entities. It currently has negative earnings. It invests in the Institutional Class of the Morgan Stanley Institutional Liquidity Funds-Money Market Portfolio (the Liquidity Funds), which is an open-end management investment company.

The stock of Ambev SA (ADR) (NYSE:ABEV) hit a new 52-week high and has $6.75 target or 4.00% above today’s $6.49 share price. The 7 months bullish chart indicates low risk for the $101.06 billion company. The 1-year high was reported on Sep, 11 by Barchart.com. If the $6.75 price target is reached, the company will be worth $4.04B more. About 2.14M shares traded. Ambev SA (ADR) (NYSE:ABEV) has risen 10.52% since September 11, 2016 and is uptrending. It has underperformed by 6.18% the S&P500.

Among 4 analysts covering AmBev SA (NYSE:ABEV), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. AmBev SA has $6.80 highest and $4.90 lowest target. $6.03’s average target is -7.09% below currents $6.49 stock price. AmBev SA had 6 analyst reports since September 17, 2015 according to SRatingsIntel. Goldman Sachs maintained the shares of ABEV in report on Monday, October 10 with “Buy” rating. The rating was downgraded by Morgan Stanley to “Equal-Weight” on Thursday, August 18. The stock of Ambev SA (ADR) (NYSE:ABEV) earned “Overweight” rating by JP Morgan on Thursday, November 10. Barclays Capital reinitiated the shares of ABEV in report on Thursday, November 3 with “Equal Weight” rating. The firm has “Hold” rating given on Friday, July 28 by Barclays Capital.

Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil firm engaged in the brewing sector. The company has market cap of $101.06 billion. The Firm produces and sells beer, carbonated soft drinks and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. It has a 8.12 P/E ratio. The Company’s activities are divided into three divisions: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as activities in Dominican Republic, Saint Vincent, Antigua, Dominica, Guatemala, El Salvador, Nicaragua and Cuba; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile, Ecuador, Peru and Colombia, and Canada, represented by Labatt’s operations, which comprises sales in Canada.

City Of London Investment Management Co Ltd holds 2.39% of its portfolio in Morgan Stanley Asia Pacific Fund Inc. for 2.21 million shares. 1607 Capital Partners Llc owns 1.27 million shares or 1.16% of their US portfolio. Moreover, Amica Mutual Insurance Co has 1.06% invested in the company for 877,988 shares. The Rhode Island-based Amica Pension Fund Board Of Trustees has invested 0.94% in the stock. Amica Retiree Medical Trust, a Rhode Island-based fund reported 76,077 shares.

About 3,280 shares traded. Morgan Stanley Asia Pacific Fund Inc. (APF) has risen 24.17% since September 11, 2016 and is uptrending. It has outperformed by 7.47% the S&P500.